Mark Rothmann
1 appearance in the program
Sessions & presentations
PS21: FDA's CDER and CBER PDUFA VII Guidance on Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Development and Implementation
Panelist
Presentation: Panel Discussion
Parallel · Thu, Sep 17 , 4:15 PM